Article Details

Lineage Cell Therapeutics, Inc. (NYSE:LCTX) Is Worth Evaluating At $2.74

Retrieved on: 2021-05-01 18:00:00

Tags for this article:

Click the tags to see associated articles and topics

Lineage Cell Therapeutics, Inc. (NYSE:LCTX) Is Worth Evaluating At $2.74. View article details on hiswai:

Excerpt

The next largest institutional holding, with 6.21 Million shares, is of Vanguard Group, Inc. (The)'s that is approximately 3.84% of outstanding shares.

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo